Literature DB >> 12031083

Differentiation between ulcerative colitis and Crohn's disease by a quantitative immunohistochemical evaluation of T lymphocytes, neutrophils, histiocytes and mast cells.

Yoshio Sasaki1, Masanori Tanaka, Hajime Kudo.   

Abstract

Mucosal biopsy criteria has limited validity in terms of discrimination between ulcerative colitis (UC) and Crohn's disease (CD). The aim of this study was to set up quantitative immunohistochemical criteria, with a special focus on inflammatory cell distribution within individual specimens and throughout the large bowel. Quantitative evaluation was performed for the density of CD8+, CD45RO+, neutrophil elastase+, CD68+ and mast cell tryptase+ cells in affected and unaffected mucosa taken from 41 patients with UC and 61 patients with CD. Each slide was examined at the highest and lowest density fields, which were further divided into the upper and deeper half of mucosa. Multiple logistic regression analysis using 51 features as independent variables constructed a predictive equation finding the probability of UC (PUC), and the diagnostic categories were subsequently defined based on a receiver-operating characteristic curve. The analysis disclosed five significant features suggesting UC; these implied intense infiltration of CD8+ and mast cell tryptase+ cells, diffuse infiltration of neutrophil elastase+ and CD68+ cells, and continuous infiltration of CD45RO+ cells. The criteria consisted of three diagnostic categories, 'suggestive of UC (PUC > or = 0.7)', 'indeterminate (0.3 < PUC < 0.7)', and 'suggestive of CD (PUC < or = 0.3)'; the criteria had values for sensitivity and specificity exceeding 95%. The immunohistochemical criteria distinguishing UC from CD may help to confirm the diagnosis in patients with ambiguous endoscopic and histological diagnosis.

Entities:  

Mesh:

Year:  2002        PMID: 12031083     DOI: 10.1046/j.1440-1827.2002.01354.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  15 in total

1.  Induction of tryptase and histamine release from human colon mast cells by IgE dependent or independent mechanisms.

Authors:  Shao-Heng He; Hua Xie; Yong-Song He
Journal:  World J Gastroenterol       Date:  2004-02-01       Impact factor: 5.742

2.  Increased expression of long pentraxin PTX3 in inflammatory bowel diseases.

Authors:  Shingo Kato; Mitsuko Ochiai; Tomoya Sakurada; Shino Ohno; Kyoko Miyamoto; Mina Sagara; Masataka Ito; Kyoko Takeuchi; Junko Imaki; Kazuro Itoh; Koji Yakabi
Journal:  Dig Dis Sci       Date:  2007-11-08       Impact factor: 3.199

Review 3.  Neuroanatomy of lower gastrointestinal pain disorders.

Authors:  Wim Vermeulen; Joris G De Man; Paul A Pelckmans; Benedicte Y De Winter
Journal:  World J Gastroenterol       Date:  2014-01-28       Impact factor: 5.742

4.  Cloning and expression of human colon mast cell carboxypeptidase.

Authors:  Zhang-Quan Chen; Shao-Heng He
Journal:  World J Gastroenterol       Date:  2004-02-01       Impact factor: 5.742

Review 5.  Key role of mast cells and their major secretory products in inflammatory bowel disease.

Authors:  Shao-Heng He
Journal:  World J Gastroenterol       Date:  2004-02-01       Impact factor: 5.742

6.  Induction and cellular expression of tartrate resistant acid phosphatase during dextran sodium sulphate induced colitis in rats.

Authors:  Pernilla Lång; Stefan Lange; Dick Delbro; Göran Andersson
Journal:  Histochem Cell Biol       Date:  2009-10-11       Impact factor: 4.304

7.  Inflamed Ulcerative Colitis Regions Associated With MRGPRX2-Mediated Mast Cell Degranulation and Cell Activation Modules, Defining a New Therapeutic Target.

Authors:  Ernie Chen; Ling-Shiang Chuang; Mamta Giri; Nicole Villaverde; Nai-Yun Hsu; Ksenija Sabic; Sari Joshowitz; Kyle Gettler; Shikha Nayar; Zhi Chai; Isaac L Alter; Colleen C Chasteau; Ujunwa M Korie; Siarhei Dzedzik; Tin Htwe Thin; Aayushee Jain; Arden Moscati; Gerardus Bongers; Richard H Duerr; Mark S Silverberg; Steven R Brant; John D Rioux; Inga Peter; L Philip Schumm; Talin Haritunians; Dermot P McGovern; Yuval Itan; Judy H Cho
Journal:  Gastroenterology       Date:  2021-01-06       Impact factor: 33.883

8.  Histamine drives severity of innate inflammation via histamine 4 receptor in murine experimental colitis.

Authors:  J B Wechsler; A Szabo; C L Hsu; R A Krier-Burris; H A Schroeder; M Y Wang; R G Carter; T E Velez; L M Aguiniga; J B Brown; M L Miller; B K Wershil; T A Barrett; P J Bryce
Journal:  Mucosal Immunol       Date:  2018-01-24       Impact factor: 7.313

9.  Mast Cells Exert Anti-Inflammatory Effects in an IL10-/- Model of Spontaneous Colitis.

Authors:  E M Lennon; L B Borst; L L Edwards; A J Moeser
Journal:  Mediators Inflamm       Date:  2018-04-17       Impact factor: 4.711

10.  Effect of oral lactulose on clinical and immunohistochemical parameters in patients with inflammatory bowel disease: a pilot study.

Authors:  Anne Hafer; Sigrid Krämer; Swantje Duncker; Martin Krüger; Michael P Manns; Stephan C Bischoff
Journal:  BMC Gastroenterol       Date:  2007-09-04       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.